This website uses cookies
Read our Privacy policy and Terms of use for more information.
Read the latest news stories in diabetes tech, research and innovation.
CGM
+2
/
Oct 26, 2026
The investigational 'Freedom' continuous glucose monitor would deliver year-long glucose monitoring without an external transmitter, with potential launch targeted for 2028.
Oct 23, 2026
Abbott’s recent app updates addresses security and lost connection bugs found in earlier versions. Libre and FreeStyle Libre 3 app users should update immediately.
News
Oct 16, 2026
The FDA clearance expands twiist to people with type 2 diabetes using insulin, following trial results showing improved time in range and A1c.
Oct 14, 2026
Tandem says a software issue may prevent the immediate portion of Extended Boluses from being delivered to users of the Android app.
+1
Oct 12, 2026
Insulet's diabetes data platform gives Omnipod 5 users and healthcare professionals personalized insights into glucose trends, insulin delivery, and therapy.
Oct 9, 2026
The glucose monitoring startup has secured new funding and partnered with Ascensia to bring its next-generation microsensor CGM to Europe.
Oct 6, 2026
Biolinq’s needle-free will soon be available OTC for adults not using insulin, expanding access to continuous glucose insights without a prescription.
+3
Tandem Diabetes' first tubeless insulin pump is expected to reach the market in 2027, creating an entirely new category of insulin pump.
Oct 5, 2026
twiist adds insulin pump control to two Android phones and smartwatches, giving more users access to the highly customizable app-controlled AID system.
Sep 28, 2026
Tandem’s smallest AID system expands overseas as the company works toward new CGM integrations, Android support, and a tubeless Mobi.
The all-in-one Libre App has rolled out internationally, expanding access to the Libre 2 and Libre 3 Plus, and an expanded feature set.
Sep 21, 2026
The open-source AID system latest updated brings upgraded features, including new CGM and pump integrations.
Sep 14, 2026
Mint launches fully in Q1 2027, and its new 3D Intelligence algorithm gives clinicians three dosing options to better fit each patient's needs.
The Eversense 365 implantable continuous glucose monitor will expand support to a second insulin pump before the end of the year.
Sep 1, 2026
MiniMed's first tubeless insulin pump could reach the market by summer 2027, and a fully closed-loop algorithm is expected soon after.
Aug 25, 2026
The newly authorized Libre Duo 10 Day will continuously track both glucose and ketones, potentially giving people with diabetes an earlier warning of rising ketone levels.
Aug 19, 2026
Awikli, the first once-weekly basal insulin for type 2 diabetes, has officially launched across the U.S., cutting basal injections down to once a week.
MiniMed Flex
Aug 17, 2026
Compatibility between the Instinct sensor and MiniMed Flex insulin pump gives users more sensor options for their diabetes management.
+4
Aug 11, 2026
The insulin pump company is expanding access to pumps by tapping into new European markets and offering pay-as-you-go benefit options for U.S. customers.
Jul 22, 2026
The update expands access to MiniMed's latest pump, with its sensor portfolio, helping reduce the day to day burden of diabetes for adults living with diabetes.
Jul 14, 2026
The new "Mind in Range" collection offers free meditations, a breathing exercise, and a narrated sleep story for the diabetes community.
Dexcom
Jul 13, 2026
Canadian adults, 18 years and older, with diabetes will have access to Dexcom's sensor with the longest wear time, setting a new standard for the company.
Dexcom's Follow app could get enhanced features like Urgent Low Soon alerts, Alert Acknowledged labels, and call notifications.
Jul 6, 2026
Spain is the latest European market that now has access to Omnipod 5 and Insulet products, with more planned to come later this year.
Jul 1, 2026
Control-IQ+ users in the UK, Switzerland, Sweden, Finland, and Italy get a new CGM option with more countries expected to follow in 2026.
